CLINICAL_TRIALS
research
· 2017-12-13
Clinical Trial Update: Probiotic (Visbiome) for Gulf War Illness [Phase 2, Phase 3]
Summary
Clinical trial update for Visbiome probiotic in Gulf War Illness, spanning Phase 2 and Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ashok Tuteja | Conditions: Gulf War Illness | Phase 2, Phase 3 | Status: UNKNOWN